The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Grow Between 2026 And 2030?
The renal toxicity – absorption, distribution, metabolism, and excretion (ADME) toxicology testing market size has seen rapid expansion in recent years. This market is anticipated to increase from $1.52 billion in 2025 to $1.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. The historical growth of this market can be ascribed to several factors, including an uptick in preclinical drug safety testing, an increase in drug failures due to nephrotoxicity, the growth of CRO services, more rigorous regulatory safety standards, and the wider integration of in vitro assays.
The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market size is projected to experience swift expansion over the coming years. This market is anticipated to reach $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth during the forecast period include a rise in biologics and complex drug development, the adoption of predictive toxicology models, the broadening of organ-on-chip platforms, advancements in precision medicine research, and an increasing demand for AI-based safety analytics. Key trends expected over the forecast period encompass kidney organoid-based toxicity assays, AI-assisted models for nephrotoxicity prediction, advanced high-throughput renal screening platforms, biomarker-driven renal safety panels, and microphysiological kidney-on-chip systems.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33295&type=smp
What Leading Drivers Are Supporting The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Expansion?
The increasing occurrence of kidney conditions is projected to boost the expansion of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market in the future. These disorders are ailments that harm the kidneys and impair their capacity to filter blood and preserve bodily equilibrium. The surge in kidney-related disorders stems from an increase in diabetes, a condition that harms kidney blood vessels and compromises their filtration capabilities. Renal toxicity ADME/toxicology testing plays a crucial role in identifying and assessing potential renal harm from drugs or chemicals, thereby facilitating prompt intervention and the creation of safer therapeutic options. For example, projections by the American Cancer Society, a US-based professional organization, indicate that in 2025, around 80,980 new kidney (renal) cancer cases will be diagnosed in the US, with an estimated 14,510 fatalities attributed to the illness. Consequently, the growing incidence of kidney-related disorders is a primary catalyst for the expansion of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market.
How Are Different Segments Classified In The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Segment Analysis?
The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market covered in this report is segmented –
1) By Test Type: In Vitro Renal Toxicity Testing; In Vivo Renal Toxicity Testing; In Silico Renal Toxicity Modeling
2) By Method: Biochemical and Enzymatic Assays; Cell Based Renal Assays; Biomarker Based Toxicity Analysis; Histopathology and Imaging; Pharmacokinetic and Drug Metabolism Studies
3) By Stage of Drug Development: Discovery and Lead Optimization; Preclinical Development; Clinical Development; Post Marketing Safety Studies
4) By Technology: High Throughput Screening Platforms; Organ On Chip and Microfluidic Systems; Omics Based Toxicology Platforms; Artificial Intelligence and Predictive Modeling Tools; Digital Pathology and Imaging Systems
5) By End User: Pharmaceutical and Biotechnology Companies; Contract Research Organizations; Academic and Research Institutes; Regulatory Laboratories
Subsegments:
1) By In Vitro Renal Toxicity Testing: Primary Renal Cell Assays; Immortalized Renal Cell Line Assays; Three Dimensional Renal Cell Cultures; Kidney Organoid Models; Transporter Interaction Assays; Biomarker Based Nephrotoxicity Assays; High Content Imaging Assays; Microphysiological Kidney System Models
2) By In Vivo Renal Toxicity Testing: Acute Renal Toxicity Studies; Subacute Renal Toxicity Studies; Subchronic Renal Toxicity Studies; Chronic Renal Toxicity Studies; Renal Biomarker Evaluation Studies; Histopathological Kidney Assessment; Dose Response Toxicity Studies; Recovery and Reversibility Studies
3) By In Silico Renal Toxicity Modeling: Quantitative Structure Activity Relationship Modeling; Machine Learning Based Toxicity Prediction; Physiologically Based Pharmacokinetic Modeling; Virtual Screening for Nephrotoxicity; Read Across Toxicity Modeling; Systems Biology Based Toxicity Modeling
What Emerging Trends Are Seen In The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market?
Major companies operating in the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market are focusing on developing innovative solutions, such as microfluidic chips designed for low drug absorption, to improve the predictive accuracy of kidney toxicity while concurrently reducing the need for animal testing. A low-drug-absorbing microfluidic chip refers to a lab-on-a-chip device specifically crafted for renal toxicity assessment that minimizes the unintentional absorption of drugs by the chip’s material, thereby ensuring a more accurate simulation of kidney functions and reliable measurement of how drugs impact renal cells. For instance, in September 2024, Emulate Inc., a US-based biotechnology firm, launched the chip-R1 rigid chip to enhance kidney toxicity testing with more precise and trustworthy results. This chip is constructed for accurate ADME and toxicology modeling in non-stretch organs like the liver and kidney, utilizing low-drug-absorbing plastics and a thin, porous polycarbonate membrane to prevent compound loss and boost drug recovery for lipophilic compounds. Its advantages include high shear stress support (up to 2.3 dyn/cm²), preactivated surfaces for streamlined workflows, and improved cellular crosstalk, while the broader benefits encompass enhanced reproducibility, accurate toxicity detection, and compatibility with current organ-chip hardware to accelerate human-relevant preclinical testing.
Who Are The Companies Driving Activity In The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market?
Major companies operating in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Pharmaron Beijing Co. Ltd., Simulations Plus Inc., GVK Biosciences Pvt. Ltd., Promega Corporation, Syngene International Ltd., SAI Life Sciences Ltd., QPS Holdings LLC, Southern Research Institute, BioIVT LLC, TCG Lifesciences Pvt. Ltd., Frontage Laboratories Inc., Symeres, TSRL Inc., BOC Sciences LLC, Vivisciences Preclinical CRO.
Get The Full Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Report:
Which Region Leads The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market In Overall Market Size?
North America was the largest region in the renal toxicity-ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33295&type=smp
Browse Through More Reports Similar to the Global Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market 2026, By The Business Research Company
Adme Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report
Renal Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Kidney Dialysis Market Report 2026
https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model